GlaxoSmithKline Intellectual Property Development Ltd
发明人:
申请号:
EP18157255.3
公开号:
EP3360876A1
申请日:
2014.03.26
申请国别(地区):
EP
年份:
2018
代理人:
摘要:
A compound of formula (I) or a salt thereofwhereinR1 represents a hydrogen atom, a methyl group or a ethyl groupR2 represents a hydrogen atom or a fluorine atomR3 represents a hydrogen atom, a methyl group or an ethyl group.The compounds are αvβ6 integrin antagonists.